Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway

Benjamin Goeppert1, Carolin Konermann, Christopher Roman Schmidt

  • 1Institute of Pathology, University Hospital Heidelberg, Germany.

Hepatology (Baltimore, Md.)
|September 5, 2013
PubMed
Abstract

Insights

This study reveals global DNA methylation changes in cholangiocarcinomas (CCs), identifying aberrant promoter methylation in cancer-related pathways like Wnt signaling. SFRP2 protein was down-regulated in biliary tract cancers, correlating with tumor stage.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cholangiocarcinomas (CCs) molecular mechanisms are poorly understood.
  • Aberrant DNA methylation is a hallmark of human cancers, but global changes in CC are largely uncharacterized.
  • Understanding epigenetic alterations is crucial for diagnosing and treating CC.

Purpose of the Study:

  • To perform a genome-wide analysis of aberrant promoter methylation in human CCs.
  • To identify key genes and signaling pathways affected by DNA methylation in CC.
  • To investigate the functional relevance of identified methylation changes.

Main Methods:

  • Genome-wide methylation profiling using methyl-CpG immunoprecipitation (MCIp) and CpG island arrays.
  • Quantitative mass spectrometry for DNA methylation confirmation.
  • Demethylation experiments with 5-aza-2'deoxycytidine (DAC) in CC cell lines.
  • Immunohistochemical staining of tissue microarrays (TMAs) for protein expression analysis.

Main Results:

  • Differentially methylated regions were enriched in cancer-related pathways, including Wnt, TGF-β, and PI3K signaling.
  • Silencing of Wnt pathway genes (e.g., SOX17, SFRP2) was reversed by DAC treatment in CC cell lines.
  • SFRP2 protein was significantly down-regulated in biliary tract cancers (BTCs) compared to normal tissues, inversely correlating with tumor stage (pT status).

Conclusions:

  • This study provides a comprehensive genome-wide methylation landscape of human CC.
  • Aberrant methylation of Wnt pathway genes is relevant in CC pathogenesis.
  • The identified epigenetic alterations serve as a basis for future research into cholangiocarcinogenesis.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...